Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Camby

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Biochimica Et Biophysica Acta|September 12, 2002
Galectins and cancerAndré Danguy, Isabelle Camby, Robert Kiss
Head & Neck|February 23, 2007
Galectins as modulators of tumor progression in head and neck squamous cell carcinomasSven Saussez, Isabelle Camby, Gerard Toubeau, et al.
Glycobiology|July 15, 2006
Galectin-1: a small protein with major functionsIsabelle Camby, Marie Le Mercier, Florence Lefranc, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|July 2, 2004
A model-based approach for automated in vitro cell tracking and chemotaxis analysesOlivier Debeir, Isabelle Camby, Robert Kiss, et al.
Expert Review of Anticancer Therapy|June 9, 2006
Present and potential future issues in glioblastoma treatmentFlorence Lefranc, Niloufar Sadeghi, Isabelle Camby, et al.
Journal of Cell Science|September 2, 2004
v-Src accelerates spontaneous motility via phosphoinositide 3-kinase, phospholipase C and phospholipase D, but abrogates chemotaxis in Rat-1 and MDCK cellsAnna Platek, Marcel Mettlen, Isabelle Camby, et al.
Biochemical and Biophysical Research Communications|July 30, 2005
Galectin-1 knocking down in human U87 glioblastoma cells alters their gene expression patternIsabelle Camby, Christine Decaestecker, Florence Lefranc, et al.
Current Medicinal Chemistry|December 16, 2006
Anti-galectin compounds as potential anti-cancer drugsLaurent Ingrassia, Isabelle Camby, Florence Lefranc, et al.
Trials|November 20, 2014
Publication practices and standards: recommendations from GSK Vaccines' author surveyIsabelle Camby, Véronique Delpire, Laurence Rouxhet, et al.
Brain Pathology (Zurich, Switzerland)|October 25, 2008
Galectin-1 is implicated in the protein kinase C epsilon/vimentin-controlled trafficking of integrin-beta1 in glioblastoma cellsShannon Fortin, Marie Le Mercier, Isabelle Camby, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Biochimica Et Biophysica Acta|September 12, 2002
Galectins and cancerAndré Danguy, Isabelle Camby, Robert Kiss
Head & Neck|February 23, 2007
Galectins as modulators of tumor progression in head and neck squamous cell carcinomasSven Saussez, Isabelle Camby, Gerard Toubeau, et al.
Glycobiology|July 15, 2006
Galectin-1: a small protein with major functionsIsabelle Camby, Marie Le Mercier, Florence Lefranc, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|July 2, 2004
A model-based approach for automated in vitro cell tracking and chemotaxis analysesOlivier Debeir, Isabelle Camby, Robert Kiss, et al.
Expert Review of Anticancer Therapy|June 9, 2006
Present and potential future issues in glioblastoma treatmentFlorence Lefranc, Niloufar Sadeghi, Isabelle Camby, et al.
Journal of Cell Science|September 2, 2004
v-Src accelerates spontaneous motility via phosphoinositide 3-kinase, phospholipase C and phospholipase D, but abrogates chemotaxis in Rat-1 and MDCK cellsAnna Platek, Marcel Mettlen, Isabelle Camby, et al.
Biochemical and Biophysical Research Communications|July 30, 2005
Galectin-1 knocking down in human U87 glioblastoma cells alters their gene expression patternIsabelle Camby, Christine Decaestecker, Florence Lefranc, et al.
Current Medicinal Chemistry|December 16, 2006
Anti-galectin compounds as potential anti-cancer drugsLaurent Ingrassia, Isabelle Camby, Florence Lefranc, et al.
Trials|November 20, 2014
Publication practices and standards: recommendations from GSK Vaccines' author surveyIsabelle Camby, Véronique Delpire, Laurence Rouxhet, et al.
Brain Pathology (Zurich, Switzerland)|October 25, 2008
Galectin-1 is implicated in the protein kinase C epsilon/vimentin-controlled trafficking of integrin-beta1 in glioblastoma cellsShannon Fortin, Marie Le Mercier, Isabelle Camby, et al.
Pageof 3